The Cannigma

MAY 1, 2023

2 3 As clinical trials around the world proceeded in the late 1960s and 1970s, patients began reporting difficulty tolerating ketamine’s unpleasant hallucinogenic and dissociative properties. Ketamine was approved by the FDA in 1970 and was immediately put to use as an important tool for war medics in the Vietnam War.

Blood Pressure 80

Blood Pressure Chronic Pain Research and Development Clinical Trials 80

Veriheal

AUGUST 31, 2020

Program between St. Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. She is entering the 8-year Dual Admit B.S./M.D. Bonaventure University and George Washington University School of Medicine. .

Research and Development 117

Research and Development Education Agriculture Patients 117

MMJ Recs

DECEMBER 22, 2023

Public discourse became more nuanced, with patients and advocacy groups championing the cause of medical marijuana as a legitimate and effective treatment option. Studies have shown the efficacy of medical cannabis in treating conditions such as chronic pain, epilepsy, and certain mental health disorders.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Cannabis Law Report

OCTOBER 17, 2019

Tree of Knowledge will be introducing chronic pain management protocols and research into the Caribbean market. The introduction of these protocols will take the form of clinical trials and research that will include the usage of specific strains of cannabis that aid in chronic pain and cancer treatments.

Clinical Trials 40

Clinical Trials Research and Development Chronic Pain CBD 40

NORML

JANUARY 18, 2019

House lawmakers introduced The Medical Cannabis Research Act of 2019 (HR 601), to facilitate federally-approved clinical trials involving cannabis. At the state level, patients in Ohio and Oklahoma now have access to medical cannabis, as sales began in both states this week. Additionally, a bipartisan coalition of U.S.

Legislation 159

Legislation Decriminalization Access Therapy 159

Cannabis Law Report

JULY 9, 2021

Patients would participate in therapy sessions to prepare for the use of psychedelics, after which the substances would be administered under the guidance and supervision of trained medical professionals. See Usona Institute, A Study of Psilocybin for Major Depressive Disorder (MDD) , Clinical Trial ID NCT03866174, available at [link].

Law 105

Law Therapy Clinical Trials Research and Development 105

The Joint Blog

APRIL 17, 2020

This study summarizes potential adverse drug events related to THC when combined with other medications Medicinal Use of Marijuana Cannabis has been used widely across North America in various state or provincial medical marijuana programs. In 2018, ProCon.org has estimated well over 3.5M

Events 48

Events THC Chronic Pain Sleep 48

Cannabis Law Report

JULY 4, 2021

Clinical trials across the EU have also shown CBD oils and other hemp products to have a potential range of benefits. Some users also claim that CBD helps with chronic pain, insomnia, and anxiety. This is true if patients have the necessary medical conditions and if other treatments have not been effective.

THC 105

THC CBD Legalization Oil 105

The Joint Blog

JUNE 2, 2020

According to a new study published in the European Journal of Pain, delivering a precise doses of THC via a specialized inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions. “The 1mg dose showed a significant pain decrease compared to the placebo. .”

Chronic Pain 58

Chronic Pain Clinical Trials Safety Marijuana 58

The Joint Blog

OCTOBER 21, 2020

Some have restrictive medical marijuana programs that only allow patients with certain conditions to have access to any cannabis medication, including marijuana and hemp. Namely, to relieve chronic pains, soothe anxiety, lessen nausea, and even aid them in sleeping better.

CBD 36

CBD Legalization Oil Hemp 36

Cannabis Law Report

DECEMBER 20, 2021

First Patient Expected to be Enrolled by Q2 of 2022. Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing product candidates for pain management, CNS disorders and anti-viral indications, signed a clinical trial agreement with Altasciences Company, Inc., BERWYN, Pa.–(BUSINESS

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Data 52

Cannabis Law Report

JUNE 11, 2019

Poirier sued following a surgical procedure that left her with chronic pain and limitations affecting her lifestyle and career. Following the incident, Poirier was prescribed numerous medications, but at the time of trial, she was only taking a muscle relaxant and cannabis. Robichaud 4. Siegrist with approval. ” 42.

Chronic Pain 45

Chronic Pain Cannabis History Treatment 45

Puff Puff Post

SEPTEMBER 16, 2019

16, 2019 /CNW/ – Québec doctors have a new tool at their disposal for learning about medical cannabis and its viability as a treatment option for their patients. The program will be offered for free to Québec physicians and is made possible by an unrestricted educational grant from Spectrum Therapeutics.

Programs 108

Programs Research and Development Education Treatment 108

Project CBD

MAY 3, 2023

Goldstein has treated thousands of patients with medical cannabis. She is the medical director of Canna-Centers Wellness & Education and the clinical advisor to Cannformatics. She is also the author of Cannabis is Medicine: How Medical Cannabis and CBD are Healing Everything from Anxiety to Chronic Pain.

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

CannaMD

NOVEMBER 8, 2019

Medical Marijuana Patients Still Receive VA Benefits. While VA doctors can’t prescribe or recommend medical marijuana ( that’s what we do ), they also can’t withhold benefits because you’re a medical cannabis patient. VA clinicians may not recommend medical marijuana.

Marijuana 85

Marijuana Treatment Research and Development Patients 85

Puff Puff Post

SEPTEMBER 16, 2019

16, 2019 /CNW/ – Québec doctors have a new tool at their disposal for learning about medical cannabis and its viability as a treatment option for their patients. The program will be offered for free to Québec physicians and is made possible by an unrestricted educational grant from Spectrum Therapeutics.

Programs 40

Programs Research and Development Education Treatment 40

The Cannigma

MARCH 12, 2021

But sometimes one unintended consequence of adult-use legalization is that the market no longer caters to medical patients. So, you have this attempt to legitimize healthcare and to adopt standards, to do things in a more scientific way, and in a more credible way, for patients and for industry. It’s a non-trivial issue.

Legalization 128

Legalization Patients Education Dispensary 128

MGC Pharma

FEBRUARY 20, 2018

CBD passes Stage 3 clinical trial for the treatment of epilepsy in children A study published last year in The New England Journal of Medicine saw scientists studying the effects of CBD on epileptic seizures in patients with Dravet syndrome, a severe epileptic disorder leading to frequent and uncontrollable seizures in children.

Research and Development 100

Research and Development Clinical Trials Patients Chronic Pain 100

Cannabis Law Report

OCTOBER 22, 2021

The increasing research on medical marijuana shows its therapeutic value for a range of health conditions, including chronic pain, cancer, arthritis, diabetes, depression, anxiety, and many more. The THX-110 program takes a unique approach to cannabinoid formulation using the Entourage Effect hypothesis (i.e.,

Research and Development 52

Research and Development Pharmaceutical Marijuana Chronic Pain 52

Cannabis Law Report

AUGUST 2, 2021

Study Results Indicate SCI-160 Has A Significant Analgesic Effect on Acute and Chronic Pain. Key findings from the pre-clinical trial are as follows: SCI-160 significantly alleviates pain up to 6 hours after injection as compared with vehicle-treated animals. TEL AVIV, Israel , Aug. ” About The Study.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Cannabis Law Report

OCTOBER 18, 2021

The increasing research on medical marijuana shows its therapeutic value for a range of health conditions, including chronic pain, cancer, arthritis, diabetes, depression, anxiety, and many more. The THX-110 program takes a unique approach to cannabinoid formulation using the Entourage Effect hypothesis (i.e.,

Research and Development 52

Research and Development Pharmaceutical Chronic Pain Therapy 52

Cannabis Law Report

NOVEMBER 15, 2021

Our lead product candidate is Envelta™, which utilizes MET to deliver enkephalin nanoparticles for acute and chronic pain including pain associated with cancer. Probudur™ is a single injection long-acting liposomal bupivacaine formulation being developed to manage post-operative pain.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

The Cannigma

APRIL 8, 2021

So yeah, I spend my time helping physicians and nurses more than I do counting bills and talking to patients. We’ve actually had one or maybe even two cannabis pharmacists on this program before. Perhaps the patient turns out to be allergic to that medicine or whatnot. CP: Yeah, I work in the Emergency Department actually.

Medicine 108

Medicine Cannabinoids Cannabis THC 108

Cannabis Law Report

AUGUST 30, 2019

Americans for Safe Access released its 2018-2019 State-of-the-State report examining state laws and regulations surrounding Patient Rights and Civil Protection from Discrimination, Access to Medicine, Ease of Navigation, Functionality of the Programs, and Consumer Safety and Provider Requirements.

Banking 45

Banking Research and Development Legislation Programs 45

Cannabis Law Report

OCTOBER 20, 2021

The CBD brand FullSend claims Nelk has conducted an “enforcement program” to put it out of business by threatening it with litigation and demanding it stop selling and advertising its products under what FullSend claims is its own mark. FullSend denies committing any infringement and says Nelk also filed complaints with Instagram in Mar.

Hemp 52

Hemp Clinical Trials CBD Legalization 52

Cannabis Law Report

OCTOBER 17, 2019

Some of the potential health benefits associated with THC and CBD, with and without the high, respectively, include reducing chronic pain such as from migraines or cancer, alleviating anxiety, reducing inflammation, and helping treat conditions such as epilepsy, PTSD, and glaucoma.

Law 40

Law Seed-To-Sale Hemp Recreational 40

NORML

JANUARY 28, 2019

The National Center for Biotechnology Information has summarized a group of FDA approved randomized clinical trials, finding evidence for cannabis as medicine. Sadly, it seems Stivers already has an answer for would-be medical cannabis patients. Kentucky’s Senate leader has taken a contradictory stance.

Data 187

Data Clinical Trials Chronic Pain Medicine 187

Cannabis Law Report

JUNE 30, 2019

New Mexico expands medical cannabis program to include protections against discrimination, reciprocity with other states’ medical programs, and three-year renewal cycle (up from one) for medial cannabis cards; and. Nebraska farmers looking to grow hemp this season have until 5 p.m. The panel also took up a bill sponsored by Rep.

Chronic Pain 40

Chronic Pain Legislation Treatment Programs 40

Cannabis Law Report

DECEMBER 30, 2019

Illinois and the US territory of Guam legalized adult-use cannabis and its retail sale, medical cannabis programs were enacted and expanded in several states, and 27 states considered legislation that would have legalized adult-use cannabis, a record-high. Continued Protections for State Legal Medical Programs.

Legislation 59

Legislation Patients Access Banking 59